Episode 2: Building on Amyloid Lowering: Key Insights from Recent Data and Prospects for Complementary Therapeutic Approaches from Cognition Conversations

Episode 2: Building on Amyloid Lowering: Key Insights from Recent Data and Prospects for Complementary Therapeutic Approaches

14 minutes Posted May 25, 2023 at 7:59 pm.

Introduction

Reactions to lecanemab results

Impact of targeting plaque

Potentially complementary strategies

Future of Alzheimer’s therapies

Conclusion

0:00

14:47

Download MP3

Share at current time

Show notes

Featuring:

Anthony Caggiano, M.D., Ph.D., Chief Medical Officer and Head of R&D, Cognition Therapeutics

Christopher H. van Dyck, M.D., Yale University School of Medicine, Professor of Psychiatry, Neurology, and Neuroscience

Director of the Division of Aging and Geriatric Psychiatry; Director of the Alzheimer’s Disease Research Center

Anton P. Porsteinsson, M.D., University of Rochester School of Medicine and Dentistry, William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine

Director of the Alzheimer’s Disease Care, Research and Education Program (AD-CARE)

Index:

← See all 6 episodes of Cognition Conversations